| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/1744666X.2013.828875 |
| P698 | PubMed publication ID | 24070046 |
| P50 | author | Rosa Faner | Q47152479 |
| P2093 | author name string | Alvar Agusti | |
| Tamara Cruz | |||
| P2860 | cites work | The natural history of chronic airflow obstruction | Q24674578 |
| Hypothesis: does COPD have an autoimmune component? | Q24678881 | ||
| Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema | Q24792405 | ||
| An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema | Q24802958 | ||
| The danger model: a renewed sense of self | Q28214633 | ||
| Defining criteria for autoimmune diseases (Witebsky's postulates revisited) | Q28255257 | ||
| TH17 cells in development: an updated view of their molecular identity and genetic programming | Q28276449 | ||
| P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke | Q28740738 | ||
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary | Q29614970 | ||
| The nature of small-airway obstruction in chronic obstructive pulmonary disease | Q29618682 | ||
| Lymphocyte homing and homeostasis | Q29619924 | ||
| Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD. | Q30496365 | ||
| Identification and clinical association of anti-cytokeratin 18 autoantibody in COPD. | Q33521000 | ||
| Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
| The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis | Q33709339 | ||
| Airway epithelial cells, cytokines, and pollutants | Q33771450 | ||
| Treating human autoimmunity: current practice and future prospects | Q33772444 | ||
| CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease | Q33866441 | ||
| Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. | Q33903742 | ||
| Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice | Q33938356 | ||
| The HLA system. First of two parts | Q34023681 | ||
| Characterisation of COPD heterogeneity in the ECLIPSE cohort | Q34149510 | ||
| Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation | Q34162461 | ||
| Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease | Q34200874 | ||
| Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers | Q34348834 | ||
| Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease | Q34538815 | ||
| Cigarette smoke induced airway inflammation is independent of NF-κB signalling | Q34562660 | ||
| Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. | Q34569888 | ||
| Autoantibodies in patients with chronic obstructive pulmonary disease | Q34584449 | ||
| Antielastin autoimmunity in tobacco smoking-induced emphysema | Q34621456 | ||
| Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema. | Q34734509 | ||
| Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease | Q35537864 | ||
| Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease | Q35677380 | ||
| CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity | Q35963185 | ||
| Th1/Th2 cells in inflammatory disease states: therapeutic implications | Q35967274 | ||
| Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis. | Q36218461 | ||
| CD8+ T cells in autoimmunity | Q36286977 | ||
| An investigation of the resolution of inflammation (catabasis) in COPD. | Q36539037 | ||
| Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity | Q36551599 | ||
| The role of Toll-like receptors in non-infectious lung injury | Q36559267 | ||
| Lung CD8+ T cells in COPD have increased expression of bacterial TLRs | Q36643067 | ||
| Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways | Q36647303 | ||
| Global burden of COPD: risk factors, prevalence, and future trends | Q36926621 | ||
| COPD: a pediatric disease | Q37079928 | ||
| Expansion of human regulatory T-cells from patients with type 1 diabetes | Q37105331 | ||
| Novel autoantigens immunogenic in COPD patients | Q37154059 | ||
| CD4+ T-regulatory cells: toward therapy for human diseases. | Q37211300 | ||
| An evolutionary history of P2X receptors | Q37279443 | ||
| Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema | Q37282977 | ||
| Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo | Q37312884 | ||
| Investigating the natural history of lung function: facts, pitfalls, and opportunities | Q37472594 | ||
| Immunologic aspects of chronic obstructive pulmonary disease | Q37506948 | ||
| Chronic obstructive pulmonary disease in non-smokers | Q37589152 | ||
| Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity | Q37777208 | ||
| Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine | Q37822219 | ||
| Phenotypical and functional specialization of FOXP3+ regulatory T cells | Q37832385 | ||
| Immunological mechanisms of allergen-specific immunotherapy | Q37861875 | ||
| Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family | Q37864700 | ||
| Evasion of COPD in smokers: at what price? | Q37946720 | ||
| Dendritic cells in pathogenesis of COPD. | Q37990591 | ||
| Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis | Q38009797 | ||
| Autoantibodies in the grocery shop: does quantity matter? | Q38097752 | ||
| High levels of lung resident CD4+CD28null cells in COPD: implications of autoimmunity. | Q39444602 | ||
| Pulmonary dendritic cells: thinking globally, acting locally | Q39637458 | ||
| Chronic obstructive pulmonary disease phenotypes: the future of COPD. | Q39867138 | ||
| Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease | Q41974760 | ||
| Facing a "slow-motion disaster"--the UN meeting on noncommunicable diseases | Q41979042 | ||
| Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. | Q43186536 | ||
| Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease | Q43275120 | ||
| Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice | Q44120942 | ||
| The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease | Q44550733 | ||
| CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease. | Q44690970 | ||
| The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort | Q44934998 | ||
| T cell depletion protects against alveolar destruction due to chronic cigarette smoke exposure in mice. | Q45589934 | ||
| Cigarette smoke-induced emphysema: A role for the B cell? | Q47658412 | ||
| Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract | Q47760160 | ||
| STAT4 activation in smokers and patients with chronic obstructive pulmonary disease | Q47946829 | ||
| Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. | Q49058919 | ||
| Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. | Q50557641 | ||
| Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD. | Q50977404 | ||
| Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. | Q51702183 | ||
| Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. | Q51716686 | ||
| Antiendothelial Cell Antibodies in Patients With COPD. | Q53288441 | ||
| Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. | Q53409072 | ||
| The global burden of disease, 1990–2020 | Q53681952 | ||
| CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. | Q54083820 | ||
| Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers. | Q54693649 | ||
| Dynamics of Dendritic Cell Phenotype and Interactions with CD4+ T Cells in Airway Inflammation and Tolerance | Q56830566 | ||
| Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease | Q56898555 | ||
| Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history | Q57891604 | ||
| The search for autoantibodies against elastin, collagen and decorin in COPD | Q57891690 | ||
| What Is Chronic Obstructive Pulmonary Disease Anyway?. Continua, Categories, Cut Points, and Moving beyond Spirometry | Q57955675 | ||
| HLA Distribution in COPD Patients | Q58840409 | ||
| Anti-Tissue Antibodies Are Related to Lung Function in Chronic Obstructive Pulmonary Disease | Q58840453 | ||
| Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking | Q58840502 | ||
| Blunted T-lymphocyte response in chronic obstructive pulmonary disease | Q58840523 | ||
| P433 | issue | 9 | |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| P304 | page(s) | 821-833 | |
| P577 | publication date | 2013-09-01 | |
| P1433 | published in | Expert Review of Clinical Immunology | Q15733763 |
| P1476 | title | Immune response in chronic obstructive pulmonary disease | |
| P478 | volume | 9 |
| Q42372570 | Autoantibodies against CD80 in patients with COPD. |
| Q28950555 | Carcinogenic effects of oil dispersants: a KEGG pathway-based RNA-seq study of human airway epithelial cells |
| Q52614707 | Cigarette smoke exposure promotes differentiation of CD4+ T cells toward Th17 cells by CD40-CD40L costimulatory pathway in mice. |
| Q38436264 | Effects of OM-85 BV in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis |
| Q37695214 | Functional interactors of three genome-wide association study genes are differentially expressed in severe chronic obstructive pulmonary disease lung tissue |
| Q64230492 | Generation and Immune Regulation of CD4CD25Foxp3 T Cells in Chronic Obstructive Pulmonary Disease |
| Q49670937 | Invasive features of small-sized lung adenocarcinoma adjoining emphysematous bullae. |
| Q91835188 | Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD) |
| Q38452733 | Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema |
| Q36145085 | Probing Cellular and Molecular Mechanisms of Cigarette Smoke-Induced Immune Response in the Progression of Chronic Obstructive Pulmonary Disease Using Multiscale Network Modeling |
| Q38771134 | Quantification of Lung PET Images: Challenges and Opportunities |
| Q63976628 | Role of medical and molecular imaging in COPD |
| Q28392048 | The impact of oil spill to lung health--Insights from an RNA-seq study of human airway epithelial cells |
| Q47993433 | Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients |
| Q47782931 | What does endotyping mean for treatment in chronic obstructive pulmonary disease? |
Search more.